Home/Filings/4/0001209191-23-036244
4//SEC Filing

Friedman Franklin Stuart 4

Accession 0001209191-23-036244

CIK 0001654151other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 4:05 PM ET

Size

5.2 KB

Accession

0001209191-23-036244

Insider Transaction Report

Form 4
Period: 2023-06-08
Transactions
  • Purchase

    Common Stock

    2023-06-08$13.88/sh+10,000$138,82810,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.87 to $13.89, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

Deciphera Pharmaceuticals, Inc.

CIK 0001654151

Entity typeother

Related Parties

1
  • filerCIK 0001794351

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:05 PM ET
Size
5.2 KB